(Reuters) – Alnylam Pharmaceuticals said on Friday it plans to appeal a ruling by the U.S. District Court for the District of Delaware on two patents asserted against Moderna for the latter’s COVID-19 vaccine Spikevax.
(Reporting by Khushi Mandowara and Leroy Leo in Bengaluru; Editing by Krishna Chandra Eluri)
